Table 1.
Characteristics of KSHV-associated malignancies
Disease | Presentation | Lineage & Primary Tumor Cell |
Clonality | KSHV Genomes |
---|---|---|---|---|
Kaposi’s sarcoma (KS) | Highly angiogenic. Lesions can be found on skin, visceral organs, or mucosal surfaces | Endothelial cell origin; tumor cells are spindle cells with mixed blood and lymphatic endothelial cell markers | Oligoclonal lesions | >99% of tumor cells contain KSHV genomes |
Primary Effusion Lymphoma (PEL) | Non-Hodgkin lymphoma; B cell expansion in body cavity | B cell; CD20-; markers resemble partially differentiated plasma cell | Monoclonal | Each tumor cell has 50–100 copies of the KSHV genome |
MulticentricCastleman’s Disease (MCD) | Plasmablastic variant of MCD | B cell; IgM λ-restricted plasmablasts | Typically polyclonal | Unknown |